CClinicalTrials.gg
CompletedNCT03632395Updated May 21, 2020

Early Detection of Postoperative Anastomotic Leak by CT

An observational study in Anastomotic Leak, sponsored by BIRENDRA KUMAR SAH. Completed at 1 site in China. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2020-05-21.

Sponsored by BIRENDRA KUMAR SAH · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
110
Ages
18 Years to 85 Years
Sex
All
01

Study summary

Postoperative anastomotic leak is rare but life threatening complication after gastric cancer surgery. Early diagnosis is key to minimize other hazards which are caused by anastomotic leak. Investigators introduced a novel method to detect early diagnosis of anastomotic leak after gastric cancer surgery.

Read the detailed description

Postoperative anastomotic leak is rare but life threatening complication after gastric cancer surgery. Early diagnosis is key to minimize other hazards which are caused by anastomotic leak. Investigators introduced a novel method to detect early diagnosis of anastomotic leak after gastric cancer surgery. Oral contrast agent is used for CT. Investigators carefully collected all the data prospectively and standard definition of anastomotic leak was applied.

02

Conditions studied

  • Anastomotic Leak

Browse trials for

Keywords

  • gastric cancer
  • postoperative complication
  • anastomotic leak
  • oral contrast agent
  • computed tomography
03

In context

Anastomotic Leak

209 studies on the registry are indexed under Anastomotic Leak; 60 are open to participants now.

This study's enrollment of 110 is below the median of 200 across 108 observational studies indexed under Anastomotic Leak.

Browse Anastomotic Leak studies →

Lead sponsor

BIRENDRA KUMAR SAH is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients who underwent gastric cancer surgery.

Inclusion criteria

Patients with gastric cancer surgery

Exclusion criteria

Exclusion Criteria:

Patients with non gastric cancer surgery

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
110 participants (actual)
Patient registry
No

Interventions

  • Diagnostic testcomputed tomography

    computed tomography

06

What researchers measure

Primary outcomes

  1. Diagnosis of anastomotic leak

    CT was routinely used to detect early anastomotic leak after gastric cancer surgery

    Time frame: 5-10 days after surgery

07

Study locations

1 site
  • Ruijin Hospital Shanghai Jiaotong University School of Medicine
    Shanghai, Shanghai 200025, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 21, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03632395
Lead sponsor
BIRENDRA KUMAR SAH
Responsible party
BIRENDRA KUMAR SAH (Surgeon, Ruijin Hospital) — Sponsor-investigator
First posted
Aug 15, 2018
Start date
Nov 1, 2015
Primary completion
Jun 1, 2018
Completion
Jun 1, 2018
Last update
May 21, 2020

Study contacts

BIRENDRA K SAH, Ph D
principal investigator · Ruijin Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion